March 5, 2001
Health
Brand-name and generic drug makers are squaring off for a costly political battle — and consumers may pick up the tab.
Let our journalists help you make sense of the noise: Subscribe to the Mother Jones Daily newsletter and get a recap of news that matters.
We Recommend
Latest
view comments